Coronavirus (COVID-19)

The Indian Health Service continues to work closely with our tribal partners and state and local public health officials to coordinate a comprehensive public health response to the ongoing COVID-19 pandemic. The federal government is working closely with state, local, tribal, and territorial partners, as well as public health partners, to respond to this public health threat.

The IHS formed a Critical Care Response Team [PDF] of expert physicians, registered nurses, and other healthcare professionals provide urgent lifesaving medical care on an as needed basis to COVID-19 patients admitted to IHS or tribal hospitals. The IHS has also rapidly deployed telehealth services Exit Disclaimer: You Are Leaving www.ihs.gov  both to maintain routine patient care and to allow critical care consultation for COVID-19 patients.

The IHS has received nearly $3 billion in funding to provide resources for IHS, tribal, and urban Indian health programs to prepare for and respond to the coronavirus pandemic. We have worked closely with tribes and urban Indian organizations throughout this pandemic to get resources out to facilities as quickly as possible. Additionally, the IHS has distributed rapid point-of-care testing systems and supplies Exit Disclaimer: You Are Leaving www.ihs.gov  and remdesivir [PDF], an investigational antiviral medicine to treat certain people in the hospital with COVID-19, at no cost to tribal and IHS facilities.

More information on the IHS response can be found in the IHS Covid-19 Response 100 Day Review [PDF – 411 KB] and Executive Summary [PDF – 207 KB]. This report covers actions taken by the IHS to support federal, tribal, and Urban Indian Organizations between March 6, 2020 through June 14, 2020.

For the latest general information about COVID-19, we encourage everyone to periodically review CDC’s COVID-19 webpage Exit Disclaimer: You Are Leaving www.ihs.gov  .

COVID-19 Vaccine Distribution and Administration by IHS Area

As of March 1, 2021, the IHS is distributing vaccine allocations of the Pfizer and Moderna vaccine. The table below shows the total number of vaccine doses distributed and administered per IHS Area to date.

Area	Total Doses Distributed*	Total Doses Administered**
Albuquerque	68,835	58,828
Bemidji	52,615	43,192
Billings	25,715	21,447
California	73,075	37,690
Great Plains	62,450	40,625
Nashville	36,095	24,490
Navajo	148,345	111,353
Oklahoma City	273,600	138,548
Phoenix	87,840	59,607
Portland	39,085	33,455
Tucson^	5,200	3,800
Grand Total	872,855	573,035

*Distributed Data Source: IHS National Supply Service Center, includes total doses ordered and anticipated to be delivered by February 26, 2021.

**Administered Data Source: CDC Clearinghouse data from Vaccine Administration Management System (VAMS) and IHS Central Aggregator Service (CAS). Data in the CDC Clearinghouse reflects prior day data. Data may be different than actual data as there are known CDC data lags and ongoing quality review of data including resolving data errors.

^The Tucson Area vaccine administration data is currently being validated.

Note: Alaska Area – all tribes chose to receive COVID-19 vaccine from the State of Alaska.

COVID-19 Cases by IHS Area

Data are reported from IHS, tribal, and urban Indian organization facilities, though reporting by tribal and urban programs is voluntary. Data reflect cases reported to the IHS through 11:59 pm on March 4, 2021.

IHS Area	Tested	Positive	Negative	Cumulative percent positive *	7-day rolling average positivity *
Alaska	527,353	11,211	446,760	2.4%	0.9%
Albuquerque	89,227	8,011	61,087	11.6%	3.5%
Bemidji	142,165	10,107	128,526	7.3%	2.5%
Billings	94,267	7,298	83,710	8.0%	1.8%
California	71,108	7,477	59,978	11.1%	10.6%
Great Plains	133,653	13,849	119,296	10.4%	6.8%
Nashville	69,690	5,906	62,843	8.6%	4.8%
Navajo	228,119	30,954	154,904	16.7%	5.3%
Oklahoma City	449,637	59,337	385,167	13.3%	5.7%
Phoenix **	163,573	23,089	139,605	14.2%	5.4%
Portland	103,130	7,224	95,118	7.1%	2.4%
Tucson	24,420	2,705	21,562	11.2%	3.2%
TOTAL	2,096,342	187,168	1,758,556	9.6%	3.7%

** Phoenix Area Tested, Positive, and Negative Tests decreased due to data reconciliation.

* Cumulative percent positive and 7-day rolling average positivity are updated three days per week.